Latest News on HOLX

Financial News Based On Company


Advertisement
Advertisement

Jana Partners push to break up Cooper Cos. could change the stock's outlook

https://www.cnbc.com/2025/11/15/jana-partners-push-to-break-up-cooper-cos-could-change-the-stocks-outlook.html
Jana announced a top portfolio position in Cooper and plans to push for strategic alternatives, including a potential combination for its contact lens unit.

P/E Ratio Insights for Hologic - Hologic ( NASDAQ:HOLX )

https://www.benzinga.com/insights/news/25/11/48879343/pe-ratio-insights-for-hologic
Looking into the current session, Hologic Inc. ( NASDAQ:HOLX ) shares are trading at $74.35, after a 0.12% increase. Moreover, over the past month, the stock increased by 6.23%, but in the past year, decreased by 5.83%.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Golden Entertainment, Inc ( Nasdaq - GDEN ) , Brighthouse Financial, Inc. ( Nasdaq - BHF ) , Forge Global Holdings, Inc. ( NYSE - FRGE ) , Hologic, Inc. ( Nasdaq - HOLX ) - VICI Properties ( NYSE:VICI )

https://www.benzinga.com/pressreleases/25/11/g48868756/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-golden-entert
BALA CYNWYD, Pa., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Hologic Expands European Reach of Genius Digital Diagnostics System

https://www.zacks.com/stock/news/2790414/hologic-expands-european-reach-of-genius-digital-diagnostics-system
HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.

Here's Why Hologic ( HOLX ) is a Strong Momentum Stock

https://www.zacks.com/stock/news/2789990/heres-why-hologic-holx-is-a-strong-momentum-stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Advertisement

Why Hologic ( HOLX ) is a Top Value Stock for the Long-Term

https://www.zacks.com/stock/news/2788522/why-hologic-holx-is-a-top-value-stock-for-the-long-term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here is What to Know Beyond Why Hologic, Inc. ( HOLX ) is a Trending Stock

https://www.zacks.com/stock/news/2787687/here-is-what-to-know-beyond-why-hologic-inc-holx-is-a-trending-stock
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal

https://www.zacks.com/stock/news/2787560/hologics-breast-health-rebounds-takes-spotlight-in-buyout-deal
After a strong Q4 rebound, HOLX's Breast Health takes center stage in the company's upcoming private equity takeover.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Golden Entertainment, Inc ( Nasdaq - GDEN ) , Brighthouse Financial, Inc. ( Nasdaq - BHF ) , Forge Global Holdings, Inc. ( NYSE - FRGE ) , Hologic, Inc. ( Nasdaq - HOLX ) - VICI Properties ( NYSE:VICI )

https://www.benzinga.com/pressreleases/25/11/g48699003/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-golden-entert
BALA CYNWYD, Pa., Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Palmer Square BDC ( PSBD ) Earnings Transcript

https://www.fool.com/earnings/call-transcripts/2025/11/05/palmer-square-bdc-psbd-earnings-transcript/
Image source: The Motley Fool.Wednesday, Nov. 5, 2025 at 1 p.m. ETChairman and Chief Executive Officer - Christopher LongContinue reading ...
Advertisement

HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands

https://www.zacks.com/stock/news/2784288/holx-stock-up-on-q4-earnings-revenue-beat-operating-margin-expands
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.

Hologic ( HOLX ) Q4 Earnings and Revenues Beat Estimates

https://www.zacks.com/stock/news/2783987/hologic-holx-q4-earnings-and-revenues-beat-estimates
Hologic (HOLX) delivered earnings and revenue surprises of +2.73% and +1.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

WOMEN'S TENNIS ASSOCIATION CELEBRATES GLOBAL STYLE AND CULTURE WITH ICONIC 2025 WTA FINALS PORTRAITS

https://www.benzinga.com/pressreleases/25/10/n48554521/womens-tennis-association-celebrates-global-style-and-culture-with-iconic-2025-wta-finals-portrait
Please find hi-res downloadable images HERE ( Photo Credit Yumna Al-Arashi/WTA )

HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment?

https://www.zacks.com/stock/news/2781244/holx-vs-abt-which-medical-technology-stock-is-the-better-investment
Hologic's $18.3B buyout deal and Abbott's strong growth across key segments set up a close contest for MedTech investors.

HOLX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Hologic to Blackstone and TPG - Hologic ( NASDAQ:HOLX )

https://www.benzinga.com/pressreleases/25/10/g48499263/holx-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-hologic-to-blackston
MONSEY, N.Y., Oct. 29, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Hologic Inc. ( NASDAQ:HOLX ) ( "Hologic" ) to Blackstone and TPG for an upfront payment of $76.00 per share in cash, and a non-tradeable contingent value ...
Advertisement

Gear Up for Hologic ( HOLX ) Q4 Earnings: Wall Street Estimates for Key Metrics

https://www.zacks.com/stock/news/2779990/gear-up-for-hologic-holx-q4-earnings-wall-street-estimates-for-key-metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Waters ( WAT ) Reports Next Week: Wall Street Expects Earnings Growth

https://www.zacks.com/stock/news/2779136/waters-wat-reports-next-week-wall-street-expects-earnings-growth
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HALPER SADEH LLC ENCOURAGES PLYM, HOLX, ATXS, PCH SHAREHOLDERS to Contact the Firm to Discuss Their Rights - Astria Therapeutics ( NASDAQ:ATXS ) , Hologic ( NASDAQ:HOLX )

https://www.benzinga.com/pressreleases/25/10/g48449042/halper-sadeh-llc-encourages-plym-holx-atxs-pch-shareholders-to-contact-the-firm-to-discuss-their-r
NEW YORK, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

What Does the Market Think About Hologic Inc? - Hologic ( NASDAQ:HOLX )

https://www.benzinga.com/insights/short-sellers/25/10/48447292/what-does-the-market-think-about-hologic-inc
Hologic Inc's ( NYSE:HOLX ) short interest as a percent of float has risen 12.5% since its last report. According to exchange reported data, there are now 3.50 million shares sold short, which is 2.07% of all regular shares that are available for trading.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. ( Nasdaq - SOHO ) , Hologic, Inc. ( Nasdaq - HOLX ) , Astria Therapeutics, Inc. ( Nasdaq - ATXS ) , PotlatchDeltic Corporation ( Nasdaq - PCH )

https://www.benzinga.com/pressreleases/25/10/g48445972/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sotherly-hote
BALA CYNWYD, Pa., Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Advertisement

Hologic ( HOLX ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

https://www.zacks.com/stock/news/2777877/hologic-holx-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release
Hologic (HOLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Trending Stock Hologic, Inc. ( HOLX ) a Buy Now?

https://www.zacks.com/stock/news/2777597/is-trending-stock-hologic-inc-holx-a-buy-now
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Deal Dispatch: Four Roses, Quantum Computing, Travis Kelce - Air France ( OTC:AFLYY ) , Alkermes ( NASDAQ:ALKS )

https://www.benzinga.com/m-a/25/10/48410718/deal-dispatch-bourbon-quantum-stakes-this-weeks-sector-shakeups
Japan's Kirin Holdings is looking to cut a deal on Kentucky bourbon brand Four Roses at around $1 billion. The problem? Young people aren't drinking as much these days. Trade tensions with Canada, a key bourbon buyer, haven't helped either.

This Winnebago Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Hologic ( NASDAQ:HOLX ) , Avadel Pharmaceuticals ( NASDAQ:AVDL )

https://www.benzinga.com/news/25/10/48377537/this-winnebago-industries-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Noah Zatzkin downgraded the rating for Winnebago Industries Inc ( NYSE:WGO ) ...

This Gartner Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Global Payments ( NYSE:GPN ) , Commercial Metals ( NYSE:CMC )

https://www.benzinga.com/analyst-stock-ratings/downgrades/25/10/48352842/this-gartner-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesda
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Andrew Schmidt downgraded the rating for Global Payments Inc ( NYSE:GPN ) from ...
Advertisement

Halper Sadeh LLC Investigates HOLX, WOW, AL, GES on Behalf of Shareholders - Guess ( NYSE:GES ) , Air Lease ( NYSE:AL )

https://www.benzinga.com/pressreleases/25/10/g48350092/halper-sadeh-llc-investigates-holx-wow-al-ges-on-behalf-of-shareholders
NEW YORK, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Why Is Hologic Stock Climbing Tuesday? - Hologic ( NASDAQ:HOLX )

https://www.benzinga.com/m-a/25/10/48333027/hologic-agrees-to-18-3-billion-buyout-by-blackstone-and-tpg
Hologic, Inc. ( NASDAQ:HOLX ) shares are trading higher after the company agreed to be acquired by funds managed by Blackstone Inc. ( NYSE:BX ) and TPG Inc. ( NASDAQ:TPG ) for an enterprise value of about $18.3 billion.

HOLX or IDXX: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2773323/holx-or-idxx-which-is-the-better-value-stock-right-now
HOLX vs. IDXX: Which Stock Is the Better Value Option?

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. ( Nasdaq - HOLX ) , TrueCar, Inc. ( Nasdaq - TRUE ) , Astria Therapeutics, Inc. ( Nasdaq - ATXS ) , PotlatchDeltic Corporation ( Nasdaq - PCH )

https://www.benzinga.com/pressreleases/25/10/g48326541/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hologic-inc-n
BALA CYNWYD, Pa., Oct. 21, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings

https://www.zacks.com/stock/news/2772100/buy-hold-or-sell-hologic-stock-key-insights-ahead-of-q4-earnings
HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.
Advertisement

Why the Market Dipped But Hologic ( HOLX ) Gained Today

https://www.zacks.com/stock/news/2770623/why-the-market-dipped-but-hologic-holx-gained-today
Hologic (HOLX) reached $68.5 at the closing of the latest trading day, reflecting a +2.24% change compared to its last close.

Is Most-Watched Stock Hologic, Inc. ( HOLX ) Worth Betting on Now?

https://www.zacks.com/stock/news/2768136/is-most-watched-stock-hologic-inc-holx-worth-betting-on-now
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

https://www.zacks.com/stock/news/2768094/holxs-enhanced-fibroid-treatment-portfolio-powers-gyn-surgical-growth
Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.

Hologic ( HOLX ) Stock Moves -1.25%: What You Should Know

https://www.zacks.com/stock/news/2766644/hologic-holx-stock-moves--125-what-you-should-know
The latest trading day saw Hologic (HOLX) settling at $67.76, representing a -1.25% change from its previous close.

Channel Medsystems Appoints Healthcare Executive Skip Baldino to Board of Directors

https://www.benzinga.com/pressreleases/25/10/g48102913/channel-medsystems-appoints-healthcare-executive-skip-baldino-to-board-of-directors
BERKELEY, Calif., Oct. 08, 2025 ( GLOBE NEWSWIRE ) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women's health with innovative solutions, announced today the appointment of Skip Baldino to its Board of Directors.
Advertisement

Hologic Expands Panther Fusion's Menu With Diagnostic Innovation

https://www.zacks.com/stock/news/2764254/hologic-expands-panther-fusions-menu-with-diagnostic-innovation
HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.

How to Play HOLX Stock This Breast Cancer Awareness Month?

https://www.zacks.com/stock/news/2762454/how-to-play-holx-stock-this-breast-cancer-awareness-month
Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.

HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests

https://www.zacks.com/stock/news/2761306/holx-stock-gains-on-fda-ce-approval-for-automated-molecular-gi-tests
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.

Why Hologic ( HOLX ) Outpaced the Stock Market Today

https://www.zacks.com/stock/news/2761035/why-hologic-holx-outpaced-the-stock-market-today
In the closing of the recent trading day, Hologic (HOLX) stood at $67.91, denoting a +1.3% move from the preceding trading day.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

https://www.zacks.com/stock/news/2760850/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Advertisement

HOLX vs. IDXX: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2760345/holx-vs-idxx-which-stock-is-the-better-value-option
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic ( HOLX Quick QuoteHOLX - ) and Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.

Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum

https://www.zacks.com/stock/news/2760083/hologic-bets-on-endomagnetics-to-fuel-interventional-breast-momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.

Why Hologic ( HOLX ) is a Top Momentum Stock for the Long-Term

https://www.zacks.com/stock/news/2759642/why-hologic-holx-is-a-top-momentum-stock-for-the-long-term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test

https://www.zacks.com/stock/news/2759555/quidelortho-expands-portfolio-with-the-launch-of-fda-approved-test
QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.

Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know

https://www.zacks.com/stock/news/2759521/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Advertisement

Volition Signs Co-Marketing and Services Agreement with Hologic - Hologic ( NASDAQ:HOLX ) , VolitionRX ( AMEX:VNRX )

https://www.benzinga.com/pressreleases/25/09/n47915069/volition-signs-co-marketing-and-services-agreement-with-hologic
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited ( NYSE: VNRX ) ( "Volition" ) , a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ( "Hologic" ) for the co-marketing of Volition's Nu.Q® Discover service.

Why Hologic ( HOLX ) Outpaced the Stock Market Today

https://www.zacks.com/stock/news/2758014/why-hologic-holx-outpaced-the-stock-market-today
Hologic (HOLX) closed at $67.21 in the latest trading session, marking a +2.16% move from the prior day.

HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?

https://www.zacks.com/stock/news/2756311/holx-to-discontinue-fluoroscan-insight-fd-soon-will-the-stock-suffer
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.

HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?

https://www.zacks.com/stock/news/2754709/holx-vs-tmo-which-diagnostic-giant-is-the-stronger-buy-today
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

908 Devices ( MASS ) Surges 7.0%: Is This an Indication of Further Gains?

https://www.zacks.com/stock/news/2754611/908-devices-mass-surges-70-is-this-an-indication-of-further-gains
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement